The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry-Reference-Cited by-同舟云学术

The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry

Published:2017-01-23 Issue:4 Volume:96 Page:653-663
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Beijers Antoinetta J.M.,Oerlemans Simone,Mols Floortje,Eurelings Marijke,Minnema Monique C.,Vreugdenhil Art,van de Poll-Franse Lonneke V.

Funder

Janssen-Cilag pharmaceutical companies of Johnson-Johnson

Jonker-Driessen Foundation

ZonMW

Population-based HAematological Registry for Observational Studies

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-017-2927-8.pdf

Reference28 articles.

1. Cavo M, Rajkumar SV, Palumbo A, Moreau P, Orlowski R, Blade J, Sezer O, Ludwig H, Dimopoulos MA, Attal M, Sonneveld P, Boccadoro M, Anderson KC, Richardson PG, Bensinger W, Johnsen HE, Kroeger N, Gahrton G, Bergsagel PL, Vesole DH, Einsele H, Jagannath S, Niesvizky R, Durie BG, San Miguel J, Lonial S, International Myeloma Working G (2011) International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation. Blood 117(23):6063–6073. doi: 10.1182/blood-2011-02-297325

2. Delforge M, Blade J, Dimopoulos MA, Facon T, Kropff M, Ludwig H, Palumbo A, Van Damme P, San-Miguel JF, Sonneveld P (2010) Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues. Lancet Oncol 11(11):1086–1095. doi: 10.1016/S1470-2045(10)70068-1

3. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA (2008) Improved survival in multiple myeloma and the impact of novel therapies. Blood 111(5):2516–2520. doi: 10.1182/blood-2007-10-116129

4. Beijers AJ, Jongen JL, Vreugdenhil G (2012) Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies. Neth J Med 70(1):18–25

5. Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32(18):1941–1967. doi: 10.1200/JCO.2013.54.0914

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of chemotherapy on operant responding for palatable food in male and female mice;Behavioural Pharmacology;2021-05-27

2. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study;Frontiers in Pharmacology;2021-04-22

3. Peripheral neuropathy in hematologic malignancies – Past, present and future;Blood Reviews;2020-09

4. Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathy;Psychopharmacology;2020-06-11

5. Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical Practice;HemaSphere;2020-05-27